testolactone has been researched along with Cancer of Prostate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Janssen, PA; Van Wauwe, JP | 1 |
| Bolton, NJ; Kontturi, M; Leinonen, P; Vihko, R | 1 |
1 review(s) available for testolactone and Cancer of Prostate
| Article | Year |
|---|---|
Is there a case for P-450 inhibitors in cancer treatment?
Topics: Aminoglutethimide; Aromatase Inhibitors; Breast Neoplasms; Cytochrome P-450 Enzyme Inhibitors; Enzyme Inhibitors; Female; Humans; Ketoconazole; Male; Neoplasms; Prostatic Neoplasms | 1989 |
1 other study(ies) available for testolactone and Cancer of Prostate
| Article | Year |
|---|---|
Rapid endocrine effects of tamoxifen and testolactone in prostatic carcinoma patients.
Topics: Aged; Endocrine Glands; Estradiol; Gonadotropins, Pituitary; Humans; Male; Prostatic Neoplasms; Steroids; Tamoxifen; Testolactone | 1982 |